SCHEMBL31267751

SCHEMBL31267751

CC(C)(C)OC(=O)N1CCN(c2ccc(Br)nn2)C(=O)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.41
MAP4K4 O95819 1/20 0.40
SMARCA2 P51531 1/20 0.40
SMARCA4 P51532 1/20 0.40
PBRM1 Q86U86 1/20 0.40
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40
ESR2 Q92731 1/20 0.39
GPR119 Q8TDV5 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE7A Q13946 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
MKNK1 Q9BUB5 1/20 0.38
POLB P06746 1/20 0.37
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31267772 1.00 NR1H2 (0.41) NR1H2MAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL29574186 0.82 PARP1 (0.42) NR1H2MAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL24265511 0.82 PARP1 (0.42) NR1H2MAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL15205695 0.82 MAP4K4 (0.42) NR1H2MAP4K4ESR2GPR119PDE4B
SCHEMBL31271932 0.81 GPR119 (0.54) MAP4K4SMARCA2SMARCA4PBRM1HTT
SCHEMBL904194 0.79 NR1H2 (0.42) NR1H2MAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL4288899 0.79 NR1H2 (0.49) NR1H2MAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL19381743 0.78 NR1H2 (0.43) NR1H2MAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL21360344 0.78 ENPP2 (0.45) NR1H2MAP4K4ESR2GPR119MKNK1
SCHEMBL1206883 0.78 ALDH1A1 (0.47) NR1H2ESR2GPR119ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724441-A1 ISOINDOLINONE AND DIHYDROPYRROLOPRIDINONE COMPOUNDS AND USES THEREOF Revir Therapeutics, Inc. (US) 2026-04-15 EP disclosed
WO-2024251212-A1 ISOINDOLINONE AND DIHYDROPYRROLOPRIDINONE COMPOUNDS AND USES THEREOF REVIR THERAPEUTICS, INC. (US) 2024-12-12 WO disclosed
WO-2024251211-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR MODULATING SPLICING OF MSH3 REVIR THERAPEUTICS, INC. (US) 2024-12-12 WO disclosed